Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 8 of 326 for:    CYTARABINE AND DAUNORUBICIN

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01463046
Recruitment Status : Completed
First Posted : November 1, 2011
Last Update Posted : April 22, 2019
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 14, 2015
Actual Study Completion Date : December 2018